Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Dosing underway in phase I trial of AR degrader GT-20029 in China

July 28, 2021

Leo Pharma begins phase IIa study of LEO-138559 for moderate to severe atopic dermatitis

July 27, 2021

PolarityTE submits IND for SkinTE in chronic cutaneous ulcers

July 27, 2021

Gilead studies GS-5718 in phase Ib for cutaneous lupus erythematosus

July 23, 2021

Dosing commences in phase II study of STP-705 for keloid scar prevention

July 15, 2021

Escient reports phase I data on EP-547 for pruritus associated with cholestasis and uremia

July 15, 2021

HT-003 reduces expression of inflammatory cytokines in acne therapeutic model

July 15, 2021

FDA clears IND for Kintor's GT-20029 for androgenetic alopecia and acne

July 14, 2021

Tyrosine-protein kinase ITK/TSK inhibitors discovered at Pfizer

July 14, 2021

EscharEx debridement agent demonstrates efficiency, safety in chronic wound study

July 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026